Result of WRAP Retail Offer

Feedback plc, (AIM: FDBK), the clinical infrastructure specialist, is pleased to confirm, further to the announcements made on 4 November 20f24 in relation to the Fundraising, the result of the Retail Offer at the Issue Price of 20 pence per share. The Company announces that it has conditionally raised aggregate gross proceeds of approximately £0.53 million pursuant to the Retail Offer, alongside the previously announced Placing and Subscription.

Accordingly, the Company will issue a total of 2,627,620 New Ordinary Shares at the Issue Price pursuant to the Retail Offer, subject to, amongst other things, the approval of the Fundraising Resolutions at the Annual General Meeting.

In total, the Fundraising has conditionally raised gross proceeds of approximately £6.1 million for the Company, via the Placing of 27,500,000 Placing Shares, a Subscription for 352,500 Subscription Shares and the issuance of 2,627,620 Retail Offer Shares (together, the "Fundraising Shares").

Admission and Total Voting Rights

Application will be made for the Fundraising Shares to be admitted to trading on AIM ("Admission"). Admission is expected to become effective on or around 8.00 a.m. on 29 November 2024.

The Retail Offer Shares will be issued free of all liens, charges and encumbrances and will, on Admission, rank pari passu in all respects with the Company's other New Ordinary Shares.

Following Admission, the Company will have 43,814,779 New Ordinary Shares in issue. The Company does not currently hold any shares in treasury. Therefore, the above figure of 43,814,779 New Ordinary Shares may be used by shareholders of the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

Terms used but not defined in this announcement have the same meaning as set out in the Company's announcement released at 7:01 a.m. on 4 November 2024.

​

Panmure Liberum Limited, which is authorised and regulated by the FCA in the United Kingdom, is acting as nominated adviser and broker to the Company in connection with the Placing and Subscription. Panmure Liberum Limited will not be responsible to any person other than the Company for providing the protections afforded to clients of Panmure Liberum Limited or for providing advice to any other person in connection with the Fundraise. Panmure Liberum Limited has not authorised the contents of, or any part of, this announcement, and no liability whatsoever is accepted by Panmure Liberum Limited for the accuracy of any information or opinions contained in this announcement or for the omission of any material information.